Ehesan U. Sharif

648 citations

26 papers · 370 indexed · h-index 10

Co-authors: George A. O’Doherty Novruz G. Akhmedov Mingde Shan Barry M. Trost Hua-Yu Leo Wang Shiyan Xu Jay P. Powers Manmohan R. Leleti
Topics: Adenosine and Purinergic Signaling (7 papers)Synthetic Organic Chemistry Methods (6 papers)Carbohydrate Chemistry and Synthesis (6 papers)
Cited by: Physiology Organic Chemistry Toxicology
Journals: Journal of the American Chemical Society Angewandte Chemie International Edition Cancer Research
Partner nations: United States Qatar Mexico

In The Last Decade

Ehesan U. Sharif

24 papers receiving 357 citations

Peers

Countries citing papers authored by Ehesan U. Sharif

Since Specialization

Citations

This map shows the geographic impact of Ehesan U. Sharif's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ehesan U. Sharif with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ehesan U. Sharif more than expected).

Fields of papers citing papers by Ehesan U. Sharif

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ehesan U. Sharif. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ehesan U. Sharif. The network helps show where Ehesan U. Sharif may publish in the future.

Co-authorship network of co-authors of Ehesan U. Sharif

This figure shows the co-authorship network connecting the top 25 collaborators of Ehesan U. Sharif. A scholar is included among the top collaborators of Ehesan U. Sharif based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ehesan U. Sharif. Ehesan U. Sharif is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Gut dysbiosis in cancer immunotherapy: microbiota-mediated resistance and emerging treatments 2025 ·Frontiers in Immunology ·(unknown),(unknown),Sumaira Anjum,Humera Kausar,Ehesan U. Sharif,Wisam Nabeel Ibrahim	2
2	Discovery and Characterization of Potent, Selective, and Orally Bioavailable 7-Azaindazole AXL Receptor Tyrosine Kinase Inhibitors 2025 ·Journal of Medicinal Chemistry ·(unknown),(unknown),(unknown),Manjunath Lamani,(unknown),Ehesan U. Sharif,Joice Thomas,Pradeep Nareddy,Gang Zhao,Yu Chen,Xiaoning Zhao,David A. Green,(unknown),Lixia Jin,(unknown),Ester Fernández‐Salas,Jay P. Powers,Manmohan R. Leleti,Dillon H. Miles	1
3	Curcumin as a novel therapeutic candidate for cancer: can this natural compound revolutionize cancer treatment? 2024 ·Frontiers in Oncology ·(unknown),Mahmoud H. A. Mohamed,(unknown),Ehesan U. Sharif,Wisam Nabeel Ibrahim	19
4	Development of a Robust and Scalable Synthetic Route for a Potent and Selective Isoindolinone PI3Kγ Inhibitor 2022 ·Organic Process Research & Development ·Artur K. Mailyan,Guillaume Mata,Dillon H. Miles,Ehesan U. Sharif,Manmohan R. Leleti,Jay P. Powers,Jenna L. Jeffrey	6
5	Discovery of Potent and Selective Methylenephosphonic Acid CD73 Inhibitors 2021 ·Journal of Medicinal Chemistry ·Ehesan U. Sharif,Jarosław Kalisiak,Kenneth V. Lawson,Dillon H. Miles,(unknown),Erick A. Lindsey,Brandon R. Rosen,Laurent Debien,Ada Chen,Xiaoning Zhao,Stephen W. Young,Nigel P.C. Walker,Norbert Sträter,Emma Rose Scaletti,Lixia Jin,Guifen Xu,Manmohan R. Leleti,Jay P. Powers	26
6	Synthesis of O‐linked Cyclitol Analogues of Gilvocarcin M and Antibacterial Activity 2021 ·Israel Journal of Chemistry ·Ehesan U. Sharif,Pei‐Yong Shi,George A. O’Doherty	1
7	Development of a Scalable and Practical Synthesis of AB928, a Dual A_2a/A_2b Receptor Antagonist 2020 ·Organic Process Research & Development ·Ehesan U. Sharif,Dillon H. Miles,Brandon R. Rosen,Jenna L. Jeffrey,Laurent Debien,Jay P. Powers,Manmohan R. Leleti	3
8	Abstract A162: AB928, a dual antagonist of the A2aR and A2bR adenosine receptors, relieves adenosine-mediated immune suppression 2019 ·Cancer Immunology Research ·Daniel DiRenzo,(unknown),Joanne B.L. Tan,Dillon H. Miles,Manmohan R. Leleti,Timothy Park,Ferdie Soriano,(unknown),Jenna L. Jeffrey,Ehesan U. Sharif,Brandon R. Rosen,Ulrike Schindler,Jay P. Powers,Matthew J. Walters	7
9	New Catalytic Asymmetric Formation of Oxygen Heterocycles Bearing Nucleoside Bases at the Anomeric Carbon 2019 ·Journal of the American Chemical Society ·Barry M. Trost,Shiyan Xu,Ehesan U. Sharif	16
10	Final results of the phase I study in healthy volunteers of AB928, a dual antagonist of the A2aR and A2bR adenosine receptors being studied as an activator of anti-tumor immune response 2018 ·Annals of Oncology ·Lisa Seitz,(unknown),Manmohan R. Leleti,Jay P. Powers,Brandon R. Rosen,Dillon H. Miles,Ehesan U. Sharif,(unknown),(unknown),S. R. Young,(unknown),(unknown),Joyson Karakunnel,(unknown)	2
11	AB928, a dual antagonist of the A 2a R and A 2b R adenosine receptors, leads to greater immune activation and reduced tumor growth when combined with chemotherapy 2018 ·European Journal of Cancer ·Ulrike Schindler,Lisa Seitz,(unknown),(unknown),Joanne B.L. Tan,Daniel DiRenzo,F Yin,Manmohan R. Leleti,Brandon R. Rosen,Dillon H. Miles,Lixia Jin,(unknown),S. R. Young,Ferdie Soriano,(unknown),Joyson Karakunnel,Ehesan U. Sharif,(unknown),(unknown)	5
12	Abstract 4572: Characterization of the potent and selective A2aR antagonist AB928 for the treatment of cancer 2017 ·Cancer Research ·(unknown),Joanne B.L. Tan,Annette Becker,Fangfang Yi,(unknown),Manmohan R. Leleti,Brandon R. Rosen,Ehesan U. Sharif,Laurent Debien,Steve Young,(unknown),(unknown),Juan C. Jaén,Jay P. Powers	9
13	Ru-catalyzed sequence for the synthesis of cyclic amido-ethers 2016 ·Chemical Science ·Barry M. Trost,Ehesan U. Sharif,(unknown)	5
14	ChemInform Abstract: Ruthenium‐Catalyzed Multicomponent Reactions: Access to α‐Silyl‐β‐Hydroxy Vinylsilanes, Stereodefined 1,3‐Dienes, and Cyclohexenes. 2016 ·ChemInform ·Barry M. Trost,Dennis C. Koester,Ehesan U. Sharif	1
15	Denovo asymmetric synthesis of the mezzettiaside family of natural products via the iterative use of a dual B-/Pd-catalyzed glycosylation 2014 ·Chemical Science ·(unknown),Ehesan U. Sharif,Novruz G. Akhmedov,George A. O’Doherty	77
16	Merremoside D: De Novo Synthesis of the Purported Structure, NMR Analysis, and Comparison of Spectral Data 2013 ·Organic Letters ·Ehesan U. Sharif,Hua-Yu Leo Wang,Novruz G. Akhmedov,George A. O’Doherty	29
17	C3′/C4′‐Stereochemical Effects of Digitoxigenin α‐L‐/α‐D‐Glycoside in Cancer Cytotoxicity 2012 ·ChemMedChem ·(unknown),(unknown),Ehesan U. Sharif,(unknown),Novruz G. Akhmedov,George A. O’Doherty	25
18	Biosynthesis and Total Synthesis Studies on the Jadomycin Family of Natural Products 2012 ·European Journal of Organic Chemistry ·Ehesan U. Sharif,George A. O’Doherty	29
19	Roles of the Synergistic Reductive O-Methyltransferase GilM and of O-Methyltransferase GilMT in the Gilvocarcin Biosynthetic Pathway 2012 ·Journal of the American Chemical Society ·Nidhi Tibrewal,(unknown),Steven G. Van Lanen,Ehesan U. Sharif,George A. O’Doherty,Jürgen Rohr	19
20	Total Synthesis of Jadomycin A and a Carbasugar Analogue of Jadomycin B 2010 ·Angewandte Chemie International Edition ·Mingde Shan,Ehesan U. Sharif,George A. O’Doherty	59

About Ehesan U. Sharif

Ehesan U. Sharif is a scholar working on Physiology, Organic Chemistry and Pharmacology, having authored 26 papers that have together received 370 indexed citations. Recurring topics across this work include Adenosine and Purinergic Signaling (7 papers), Synthetic Organic Chemistry Methods (6 papers) and Carbohydrate Chemistry and Synthesis (6 papers). The work is most often cited by research in Physiology (48 citations), Organic Chemistry (252 citations) and Toxicology (21 citations). Ehesan U. Sharif has collaborated with scholars based in United States, Qatar and Mexico. Frequent co-authors include George A. O’Doherty, Novruz G. Akhmedov, Mingde Shan, Barry M. Trost, Hua-Yu Leo Wang, Shiyan Xu, Jay P. Powers, Manmohan R. Leleti, Dillon H. Miles and Brandon R. Rosen. Their work appears in journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact